Clinical Trial

Evaluation of the GORE® TBE Device in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 0/1

Study acronym: SSB 11-02
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The objective of this study is to determine whether the GORE® TAG® Thoracic Branch Endoprosthesis is safe and effective in treating lesions of the aortic arch and descending thoracic aorta.
Protocol Amendment History 25 amendments
This ClinicalTrials.gov record has been amended 25 times since 2016-05-16; most recent amendment 2025-06-18.
Status change: Recruiting → Active, Not Recruiting 2023-02-09
Status change: Not Yet Recruiting → Recruiting 2016-08-17
Trial Details
NCT Number NCT02777528
Lead Sponsor W.L.Gore & Associates
Conditions Aortic Aneurysm, Thoracic, Aorta, Lesion
Enrollment 79 participants
Start Date 2016-08
Primary Completion 2024-03 (estimated)
Study Completion 2028-03 (estimated)
Updated on ClinicalTrials.gov 2025-06-25